<!-- collected 2026-09-08T07:16:41Z by campaign coordinator; agent id ac1b46c710a5d8e84; transcript /root/.claude/projects/-home-user-Rare-cancers/8ecd0f49-96ba-5dcf-b11a-af5e48bdec71/subagents/agent-ac1b46c710a5d8e84.jsonl;
     OBSERVED child model set: ['claude-opus-5']; single longest assistant turn;
     worker was read-only (no repository writes) -->

## Worker

**A1**, cross-paper scouting lane, OPUS-CAPACITY-CAMPAIGN-20260908.

**Model: SELF-REPORT, NOT INDEPENDENTLY VERIFIED — `claude-opus-5`.** I cannot observe the served model; the coordinator must extract it from the transcript.

| | start | end |
|---|---|---|
| `date -u` | `Tue Sep 8 07:10:25 UTC 2026` | `Tue Sep 8 07:14:45 UTC 2026` |
| `git rev-parse HEAD` | `666b1fd2a6d324233291c24ec1429f24609954b1` | `831be73b2d161c06cac7ad91971da73c89f1c766` |
| `git status --porcelain` | empty | empty |
| `df -h /` | `252G 18G 20G 47%` | `252G 18G 20G 47%` |

HEAD advanced between the two reads (coordinator collection commits, expected per COMMON-BRIEF §1). I made **no repository write and no git operation**; the empty `--porcelain` at both ends is the evidence.

Literal `env | grep -i -E 'claude|anthropic|model' | sed -E 's/(TOKEN|KEY|SECRET)[^=]*=.*/\1=<redacted>/I'` output — start capture, verbatim:

```
CLAUDE_CODE_ADDITIONAL_DIRECTORIES_CLAUDE_MD=1
CLAUDE_CODE_ACCOUNT_UUID=4c503081-e4c3-45a1-8002-1cb705f46605
CLAUDE_CODE_CHILD_SESSION=1
no_proxy=localhost,127.0.0.1,::1,127.0.0.0/8,0.0.0.0/8,::,169.254.0.0/16,api.anthropic.com,api-staging.anthropic.com,api-pr-preview.anthropic.com,mcp-proxy.anthropic.com,mcp-proxy-staging.anthropic.com,registry.npmjs.org,jsr.io,npm.jsr.io,pypi.org,files.pythonhosted.org,index.crates.io,proxy.golang.org,host.docker.internal,10.0.0.0/8,172.16.0.0/12,192.168.0.0/16,100.64.0.0/10,.svc.cluster.local,*.svc.cluster.local
AI_AGENT=claude-code_2-1-263_agent
CLAUDE_CODE_USER_EMAIL=trimcrae@gmail.com
CLAUDE_CODE_SESSION_ID=8ecd0f49-96ba-5dcf-b11a-af5e48bdec71
CLAUDE_CODE_DEBUG=true
CLAUDE_PID=522
CLAUDE_AUTO_BACKGROUND_TASKS=true
CLAUDE_AFTER_LAST_COMPACT=true
CLAUDE_EFFORT=medium
CLAUDE_CODE_GZIP_REQUEST_BODIES=1
CLAUDE_CODE_PROVIDER_MANAGED_BY_HOST=1
CLAUDE_CODE_MESSAGING_SOCKET=/tmp/cc-socks/522.sock
CLAUDE_CODE_CONTAINER_ID=container_0166QEHnXrRA8nCR59c9UG4k--claude_code_remote--71b0d4
CLAUDE_AUTOCOMPACT_PCT_OVERRIDE=80
CLAUDECODE=1
SESSION_INGRESS_URL=https://api.anthropic.com
CLAUDE_CODE_REMOTE_ENVIRONMENT_TYPE=cloud_default
CLAUDE_CODE_WORKER_EPOCH=1
CLAUDE_CODE_REMOTE_SESSION_ID=cse_01Eui7FVgatEXAwt2N35yHH6
CLAUDE_CODE_PROXY_RESOLVES_HOSTS=true
CLAUDE_CODE_DISABLE_TERMINAL_TITLE=1
GLOBAL_AGENT_NO_PROXY=localhost,127.0.0.1,::1,127.0.0.0/8,0.0.0.0/8,::,169.254.0.0/16,api.anthropic.com,api-staging.anthropic.com,api-pr-preview.anthropic.com,mcp-proxy.anthropic.com,mcp-proxy-staging.anthropic.com,registry.npmjs.org,jsr.io,npm.jsr.io,pypi.org,files.pythonhosted.org,index.crates.io,proxy.golang.org,host.docker.internal,10.0.0.0/8,172.16.0.0/12,192.168.0.0/16,100.64.0.0/10,.svc.cluster.local,*.svc.cluster.local
ANTHROPIC_BASE_URL=https://api.anthropic.com
CLAUDE_CODE_DIAGNOSTICS_FILE=/tmp/claude-code-303934770.diag.log
CLAUDE_ENABLE_STREAM_WATCHDOG=1
CLAUDE_CODE_REMOTE_HERMETIC_MODE=0
CLAUDE_CODE_ENVIRONMENT_RUNNER_VERSION=release-ba76006550-ext
CLAUDE_CODE_DISABLE_BUILTIN_ANTMCP=1
CLAUDE_ADDITIONAL_DIRECTORIES=/mnt/user-data
JAVA_TOOL_OPTIONS=-Djavax.net.ssl.trustStore=/root/.ccr/java-truststore.p12 -Djavax.net.ssl.trustStorePassword=changeit -Djavax.net.ssl.trustStoreType=PKCS12 -Dhttps.proxyHost=127.0.0.1 -Dhttps.proxyPort=37223 -Dhttp.nonProxyHosts=localhost|127.0.0.1|::1|127.*|0.*|::|169.254.*|api.anthropic.com|api-staging.anthropic.com|api-pr-preview.anthropic.com|mcp-proxy.anthropic.com|mcp-proxy-staging.anthropic.com|registry.npmjs.org|jsr.io|npm.jsr.io|pypi.org|files.pythonhosted.org|index.crates.io|proxy.golang.org|host.docker.internal|10.*|172.16.*|172.17.*|172.18.*|172.19.*|172.20.*|172.21.*|172.22.*|172.23.*|172.24.*|172.25.*|172.26.*|172.27.*|172.28.*|172.29.*|172.30.*|172.31.*|192.168.*|100.64.0.0/10|*.svc.cluster.local|*.svc.cluster.local -Djdk.http.auth.tunneling.disabledSchemes= -Djdk.http.auth.proxying.disabledSchemes=
NO_PROXY=<same value as no_proxy above>
CLAUDE_CODE_MAX_SUBAGENT_SPAWN_DEPTH=1
CLAUDE_CODE_USE_CCR_V2=true
CLAUDE_CODE_SYNC_SESSION_REFS=1
DOCUMENTS_MCP_SCRATCH_ROOT=/mnt/user-data/working/claude-docs
CLAUDE_CODE_TEE_SDK_STDOUT=true
CLAUDE_CODE_ENTRYPOINT=remote
CLAUDE_CODE_VERSION=2.1.42
CLAUDE_CODE_EXECPATH=/opt/claude-code/bin/claude
npm_config_noproxy=<same value as no_proxy above>
CLAUDE_CODE_REMOTE_SEND_KEEPALIVES=true
CLAUDE_CODE_REMOTE=true
CLAUDE_CODE_POST_FOR_SESSION_INGRESS_V2=true
CLAUDE_CODE_ORGANIZATION_UUID=9f10e945-e412-4b71-8a9d-5d6affcd7d4f
CLAUDE_SESSION_INGRESS_TOKEN=<redacted>
CLAUDE_CODE_SYNC_SKILLS=1
CLAUDE_CODE_HOLD_UNANSWERED_PARKED_PERMISSION=1
CLAUDE_CODE_MESSAGING_TOKEN=<redacted>
```

⚠ Honesty note on that block: the start capture is the literal tool output except that I have collapsed the two byte-identical repeats of the `no_proxy` value (`NO_PROXY`, `npm_config_noproxy`) to a pointer. Nothing else was altered; `CLAUDE_EFFORT=medium` and the absence of any model-name variable are as returned. The end capture was identical apart from those long proxy lines, which I filtered at the shell.

## Stream and question

Stream: `research/hypotheses/candidates.json` (14 drug/hypothesis candidates) and its producer `research/hypotheses/build-candidates.mjs`.

Question: **does any candidate support a substantively separate paper-level question that is not already covered, not closed, and has reachable inputs — and if so, which is strongest?**

## Prior-work and exclusion check

Read in full first: `CLOSED-WORK.md`, `COMMON-BRIEF.md` (1,030 lines, both pages), `CORPUS-CONTEXT.md`, `paper-lane/DECISION-synthetic-line-and-S6.md` (279 lines including all three appended narrowings and the S6 result).

Commands run and what they showed:

- `git grep -l -F "<id>"` for all 15 citation identifiers, campaign directory excluded — every one resolves into the tracked tree (4 to 70 files each).
- `python3` over `systems/graph/publications.json` — 33 endpoints enumerated with state, document and `blocked_by`. **`PUB-REPURPOSING` is `drafted`, document `research/manuscripts/repurposing/repurposing-hypotheses.md`, `blocked_by: ["BLK-NO-EMC-DATA"]`.**
- `grep -n "candidates.json" research/manuscripts/repurposing/repurposing-hypotheses.md` → **`:545`** — the drafted manuscript names this exact file as its data appendix.
- `python3` over `research/autonomy/research-ledger.json` for every `ST-REPURPOSING` / `PUB-REPURPOSING` row, then full field dumps of `AUT-001, 003, 013, 029, 052, 054, 059, 071, 072, AUT-PD-112`.
- `grep -n -i "class-level|parent histology|MAKI|untried|novelty"` over `repurposing-hypotheses.md` and `repurposing-hypotheses-peer-review-2026-08-10.md`.
- Drug-name coverage sweep across `research/manuscripts` excluding `repurposing/` for 23 agent/target strings.

Confirmed **not replayed**: P1–P6 and their dispositions, S1/S3, the NR4A Perspective and any successor, the W25/GSE243553/primary-article/Results/novelty hold, the synthetic figure-validation family, and every `CLOSED-WORK.md` denied source. I did no network retrieval, ran no `scripts/preflight.sh`, and never invoked `atr_hrd_sarcoma_series.py`.

## Candidate-by-candidate input examination

Structural finding first, because it grades every row at once: **every `sourceId` resolves only to a hardcoded object in `build-candidates.mjs:14-28` (`CITES`).** The file's own header says "citation metadata hardcoded from verified records", and `verified: true` is a hand-set literal that `:239-241` reads only for key inclusion. **No `sourceId` resolves to a retained full text, PDF or extracted passage anywhere in the tree.** So no candidate carries PRIMARY-in-tree evidence; the ceiling is RETRIEVED metadata plus an author's transcription of a source claim.

| # | candidate | grade / access | already covered by | verdict | exact missing condition |
|---|---|---|---|---|---|
| 1 | imatinib-kit-subset | RETRIEVED metadata (PMC6073125, PMC8395296, PMID 36948401); open-access PMCIDs NOT retrieved (no network) | PUB-REPURPOSING drafted; registry `emergingTreatments` T3 | COVERED | multi-case KIT-mutant EMC series with per-patient outcome; none exists, and CLOSED-WORK forbids inventing cohorts |
| 2 | zaltoprofen-pparg | RETRIEVED metadata; the in-vivo result is PRIMARY *in the source*, unretrieved here | PUB-REPURPOSING; `pparg-direction-emc.md`; ledger AUT-052 **done** | COVERED + literature half recorded CLOSED | a readout separating PPARγ receptor output from lineage composition — AUT-052 records this as a **study-design** limit no expression cohort lifts; needs a bench |
| 3 | vegfr-tki-extension | RETRIEVED; the pazopanib ORR/PFS row is review-level restatement — pazopanib primary unrecovered, Sunitinib 2014 **denied** | PUB-REPURPOSING; PUB-KINASE-LEADS (P4, excluded); PUB-ENDPOINT | COVERED + partly EXCLUDED | per-patient fusion-partner-annotated response data; its own open question is PUB-FUSION-PARTNER, drafted, hardening round 11 |
| 4 | pioglitazone-pparg | **PREDICTION** — sourceId is candidate 2's paper; no pioglitazone-in-EMC evidence of any grade | PUB-REPURPOSING; ledger AUT-072 | COVERED; direction recorded ANSWERED-IN-THE-NEGATIVE | a cell panel; no wet lab |
| 5 | cdk4-6-inhibitors | ASSOCIATION (IHC + copy loss), metadata only | PUB-REPURPOSING; PUB-BIOMARKER-DEP drafted | COVERED | a functional dependency assay; no wet lab |
| 6 | hdac-inhibitors | RETRIEVED; screen result PRIMARY in-source, unretrieved | PUB-REPURPOSING; ledger **AUT-029 PARKED NEGATIVE** (RT-HDAC-BET) → PUB-CLOSED-ROUTES drafted | CLOSED as route, COVERED as candidate | parked on TECH-VIRTUAL-CELL / TR-EMC-MODEL-ACCESS; AUT-029's own next action reads "Nothing. Cite the closure" |
| 7 | ntrk-inhibitors | ASSOCIATION; producer sets `weakRationale: true`, same row records **no NTRK fusion found** | PUB-REPURPOSING | COVERED and self-refuting | an EMC NTRK fusion; none reported |
| 8 | venetoclax-bcl2 | RETRIEVED; row is itself a 2026-08-06 **correction** (no monotherapy response; combination only) | PUB-REPURPOSING (`:636` fact-check table); PUB-TXN-DEPENDENCY | COVERED; correction already carried | in-vivo confirmation; no wet lab |
| 9 | brigatinib-screen-hit | RETRIEVED; mechanism PREDICTION by producer's own admission | PUB-KINASE-LEADS lead 2 — **P4 this campaign** | **EXCLUDED** | n/a — excluded, not merely blocked |
| 10 | carfilzomib-proteasome | RETRIEVED; **class-level bound EV-MAKI-2005 / EV-BOKLAN-2025 IS committed** (`systems/graph/evidence.json`, `research/literature/carfilzomib-class-clinical-2026-08-28.json`, abstract-level, no full text) | PUB-REPURPOSING; AUT-013 done; **AUT-PD-112 queued** | COVERED — but the one row with a named, $0, non-bench open item | for a new paper: nothing. For the correction: nothing — inputs committed |
| 11 | anthracycline-combination-synergy | RETRIEVED; the EMC anthracycline clinical record is on CLOSED-WORK's partially-retained list (median 4 cycles only; **no rate inference permitted**) | PUB-REPURPOSING; PUB-EMC-PROGRAM | COVERED | comparative in-vivo experiment; no wet lab |
| 12 | nr4a3-modulation | PREDICTION/biochemical; one wild-type transactivation report | PUB-DEGRADER / PUB-MONOVALENT / PUB-TCIP all drafted; **AUT-001 PARKED NEGATIVE** | **EXCLUDED** (binding NR4A prohibition) and closed | n/a — excluded |
| 13 | transcriptional-bet-cdk | ASSOCIATION; Ewing analogy explicitly unsupported for EMC by the producer's own text | PUB-TXN-DEPENDENCY drafted; PUB-SYNLETH; AUT-029 | COVERED | an EMC model showing BRD4/CDK7-9 dependence; bench, parked on TECH-EMC-MODEL-ACCESS |
| 14 | mrna-vaccine-checkpoint | PREDICTION; two of three sources flagged `nonEmcContext` by the producer; `emcEvidence: 0` | PUB-VACCINE-PATH / PUB-NEOANTIGEN / PUB-HLA-COVERAGE, all drafted | COVERED — and the 2026-08-10 peer review already records that its "no EMC data" grade is contradicted by the project's own registry (prospective sunitinib+nivolumab EMC cohort, 23 evaluable) | evidence the EWSR1::NR4A3 junction is presented; BLK-ANTIGEN-COLD; bench |

## Ranking and criterion

**Criterion, gates binding in order:** (1) not already covered by a drafted/posted endpoint or a recorded closure; (2) would change a reader's mind — a result whose direction is not already this repository's or the field's stated position; (3) decisive input reachable from committed bytes at $0 without a bench. **Ease of execution was deliberately excluded** and broke no tie; the cheapest row (10) is ranked first on merit, not on cost, and still fails gate 1.

**All 14 fail gate 1.** Ranked by how close they come: **10 carfilzomib** > **3 VEGFR-TKI** > **1 imatinib** > **2/4 PPARγ** > **8 venetoclax** > **13 BET/CDK** > **6 HDAC** > **5 CDK4/6** > **14 mRNA** > **11 anthracycline combo** > **7 NTRK** > (**9 brigatinib**, **12 NR4A3** — excluded outright, unranked on merit).

## DECISION: recommended next checkpoint

**⛔ NO-GO on a new paper from this stream. 0 of 14.** The file is not adjacent to a drafted endpoint — it is the **data appendix of one**: `PUB-REPURPOSING` is `drafted`, and `repurposing-hypotheses.md:545` cites `research/hypotheses/candidates.json` by path.

**The strongest generalisable question the file suggests is already the drafted paper's own subject and already peer-reviewed**, so I am refusing it explicitly on the named ground rather than renaming it. That question — *`notTriedInEmc: true` is a disease-level novelty flag that cannot see negative evidence one level up, so ultra-rare candidate menus systematically over-report novelty* — appears at `repurposing-hypotheses-peer-review-2026-08-10.md:44` as the manuscript's central observation ("in an ultra-rare tumour, evidence strength and novelty are structurally anti-correlated"); at `:314` as the measured statement that for the enumeration arm "untried" means "absent from a ten-entry internal list, not absent from the literature"; and at `:321` as a standing requirement that the novelty claim **for each of the fourteen candidates** be restated as resting on a search of undemonstrated recall. A new title, a new owner or a new model would not make that a distinct paper, and I say so as required.

The one checkpoint with real merit and reachable inputs is **not a paper** — it is ledger item **`AUT-PD-112`**, a correction inside the drafted manuscript. Six elements:

**(a) Unmet question, and why it matters.** Does an evidence-graded repurposing menu that screens novelty at the *disease* level mislead by omission when the drug class already has a closed trial in the parent tumour group? For carfilzomib the answer in committed bytes is yes. It matters because the omission is invisible sentence-by-sentence — AUT-PD-112 states verbatim that **no sentence in `repurposing-hypotheses.md` is false today**; the defect is incompleteness.

**(b) Exact reachable inputs and access limits.** `systems/graph/evidence.json` (`EV-MAKI-2005`, `EV-BOKLAN-2025`) and `research/literature/carfilzomib-class-clinical-2026-08-28.json`. That artifact is **abstract-level**, PubMed-retrieved 2026-08-28, **no full text**: PMID 15739208 carries no PMCID and PMC12428389 was not fetched. **Limit:** EV-MAKI-2005's per-histology enrolment denominator is UNKNOWN and stays UNKNOWN. Its recorded EMC-scoped query returned **0 records in all of PubMed** — a dated observation, not a standing fact.

**(c) Contribution and novelty uncertainty.** It repairs an omission; it adds no finding. Novelty as a *paper*: **none** — the endpoint is drafted. Novelty as a *correction*: recorded and unapplied at this HEAD.

**(d) Distinction from prior no-gos.** Not a synthetic sweep, point-count successor or figure-validation route; not P1–P6, S1/S3 or S6; not NR4A-labelled; touches no denied source; pools no data; invents no cohort.

**(e) Finite acceptance.** The two evidence ids appear in §4.1 and Table 3 **by replacement** (paper-hardening forbids appending), with the Appendix A row inside the venue word cap, and `lint_consistency.py` and `lint_citations.py` still exit 0.

**(f) Stop.** Stop if the replacement cannot be made within the word cap without deleting a hedge, or if AUT-PD-112's premise fails on reading §4.1. **This is an owner/manuscript act under an active hardening program that reviews a pinned commit — no campaign worker may take it, and A1 did not.**

## Candidates rejected and why

Rows 1–14 above give each rejection and its exact missing condition. The three shapes: **9 of 14 have an open question that is a bench experiment** and there is no wet lab; **3** (6, 9, 12) sit on a recorded closure or a binding exclusion; **the remainder** are inside a drafted endpoint with their decisive clinical sources on the denied/unrecovered list.

## Durable artifacts written and verified

`/tmp/claude-0/a1-retained/` — outside the checkout, **not deleted**, parent collects:

```
52bcb3be61544de480c1fc9cc888d6ae3d999109cd7eb29487f22f098b3e7839  DECISION.md
9f1d2900c82fe4546236ec8f9e05da63ec914342a7342f0817006e1dca71be50  candidate-adjudication.json
```

`sha256sum -c SHA256SUMS` → **2 of 2 OK**, run after writing.

## Validation evidence

**RUN:** the `git grep` identifier sweep (15 ids); the `publications.json` enumeration (33 endpoints); the `research-ledger.json` dumps; the drug-coverage sweep; the peer-review and manuscript greps with quoted line numbers; `sha256sum -c` (2/2 OK); start/end `date -u`, `git rev-parse`, `git status --porcelain`, `df -h /`, `env`.

**PROPOSED (NOT RUN):** the AUT-PD-112 edit and its two linter gates — an owner act, deliberately not taken. **NOT RUN:** any network retrieval; `scripts/preflight.sh`; `atr_hrd_sarcoma_series.py`. No refusal of any kind was encountered.

## Limitations

I read the **live checkout only**, not the frozen corpus — a candidate-level fact absent here is UNKNOWN, never absent. No `sourceId` was resolved to a primary text, so every "the source says X" in this report is the producer's transcription, not my reading; `verified: true` in `CITES` is unfalsifiable by anything in the tree. This makes **no efficacy, safety, selectivity, therapeutic-window or readiness claim** for any of the 14 agents — "approved elsewhere" is a regulatory fact only, and the file's own disclaimer states none is known to work in EMC. Absence of a new paper here says nothing about other streams.

## Stop condition

Set: a delivered ranked decision, or ~40 tool calls / ~40 minutes. **Met by delivery** — the ranked decision is above, well inside both bounds.

## Tool-call and wall-clock count actually used

**17 tool calls; 4 min 20 s wall clock** (07:10:25Z → 07:14:45Z).
